Collegium Pharmaceutical, Inc. (COLL)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS19459J1043
24.87 USD
+0.24% today Updated 12 Nov 2026 20:26
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Collegium Pharmaceutical, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
25 Feb 2027
in 104 days · 08:00 · estimate 1.92
Last results
1.96 vs 1.86 estimated
05 Nov 2026 · Beat +5.6%
Beat the estimate
9 of 12
3 missed · 0 in line · 3 beats in a row
Average surprise
+7.5%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 08:00 | 1.92 | — | — | Upcoming |
| 05 Nov 2026 07:00 | 1.86 | 1.96 | +5.6% | Beat |
| 06 Aug 2026 07:00 | 1.77 | 1.92 | +8.8% | Beat |
| 07 May 2026 07:00 | 1.52 | 1.76 | +15.5% | Beat |
| 26 Feb 2026 07:00 | 2.14 | 2.04 | -4.7% | Miss |
| 06 Nov 2025 07:00 | 1.86 | 2.25 | +21.0% | Beat |
| 07 Aug 2025 07:00 | 1.85 | 1.68 | -9.2% | Miss |
| 08 May 2025 16:00 | 1.45 | 1.49 | +2.8% | Beat |
| 27 Feb 2025 16:00 | 1.54 | 1.77 | +15.1% | Beat |
| 07 Nov 2024 16:00 | 1.59 | 1.61 | +1.1% | Beat |
| 08 Aug 2024 16:00 | 1.49 | 1.62 | +9.0% | Beat |
| 09 May 2024 16:00 | 1.47 | 1.45 | -1.4% | Miss |
| 22 Feb 2024 16:00 | 1.25 | 1.58 | +25.9% | Beat |
| 07 Nov 2023 16:00 | 1.24 | 1.34 | +8.3% | Beat |
| 03 Aug 2023 16:00 | 1.22 | 1.26 | +3.5% | Beat |
| 04 May 2023 16:00 | 1.51 | 1.32 | -12.8% | Miss |
| 23 Feb 2023 16:00 | 1.26 | 1.09 | -13.7% | Miss |
| 03 Nov 2022 16:00 | 1.38 | 1.10 | -20.4% | Miss |
| 04 Aug 2022 16:00 | 1.44 | 1.21 | -15.8% | Miss |
| 10 May 2022 16:00 | 0.90 | 0.91 | +1.2% | Beat |
| 24 Feb 2022 16:00 | 1.04 | -0.18 | -117.5% | Miss |
| 04 Nov 2021 16:00 | 0.96 | 0.78 | -18.4% | Miss |
| 05 Aug 2021 16:00 | 0.95 | 0.81 | -14.8% | Miss |
| 06 May 2021 16:00 | 1.00 | 0.96 | -4.8% | Miss |
| 25 Feb 2021 16:00 | 0.97 | 0.93 | -4.1% | Miss |
| 05 Nov 2020 16:00 | 0.90 | 1.03 | +14.5% | Beat |
| 05 Aug 2020 16:00 | 0.86 | 0.95 | +10.2% | Beat |
| 07 May 2020 17:00 | 0.66 | 0.89 | +34.7% | Beat |
| 27 Feb 2020 16:00 | 0.10 | 0.16 | +57.1% | Beat |
| 06 Nov 2019 16:00 | 0.03 | 0.05 | +81.1% | Beat |
| 07 Aug 2019 16:00 | -0.04 | 0.09 | +316.9% | Beat |
| 08 May 2019 16:00 | -0.15 | -0.05 | +64.3% | Beat |
| 27 Feb 2019 16:00 | -0.12 | -0.10 | +17.1% | Beat |
| 08 Nov 2018 16:00 | -0.12 | -0.25 | -104.7% | Miss |
| 08 Aug 2018 16:00 | -0.33 | -0.15 | +55.1% | Beat |
| 09 May 2018 16:00 | -0.65 | -0.57 | +12.0% | Beat |
| 07 Mar 2018 16:00 | -0.55 | -0.54 | +2.5% | Beat |
| 08 Nov 2017 16:00 | -0.73 | -0.45 | +38.2% | Beat |
| 09 Aug 2017 16:00 | -0.80 | -0.72 | +10.6% | Beat |
| 10 May 2017 16:00 | -1.00 | -0.79 | +20.8% | Beat |
| 09 Mar 2017 16:00 | -1.08 | -1.02 | +5.6% | Beat |
| 10 Nov 2016 16:00 | -1.11 | -1.13 | -1.4% | Miss |
| 10 Aug 2016 16:00 | -0.82 | -1.05 | -27.7% | Miss |
| 10 May 2016 16:00 | -0.49 | -0.68 | -38.1% | Miss |
| 18 Mar 2016 17:00 | -0.43 | -0.46 | -5.8% | Miss |
| 12 Nov 2015 06:00 | -0.29 | -0.46 | -58.6% | Miss |
| 12 Aug 2015 17:00 | -0.31 | -0.45 | -45.2% | Miss |
| 22 Jun 2015 17:00 | -0.16 | -0.18 | -14.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 780.6M | +23.6% | 62.9M | 8.1% | 1.73 | -7.0% | 327.6M |
| 2024 | 631.4M | +11.4% | 69.2M | 11.0% | 1.86 | +44.2% | 203.3M |
| 2023 | 566.8M | +22.2% | 48.2M | 8.5% | 1.29 | +274.3% | 274.3M |
| 2022 | 463.9M | — | -25M | -5.4% | -0.74 | — | 122.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 25.06 | 25.12 | 24.52 | 24.87 | +0.24% | 269,142 | |
| 11 Nov 2026 | 24.13 | 24.83 | 23.99 | 24.81 | +1.39% | 500,400 | |
| 10 Nov 2026 | 24.46 | 24.95 | 24.14 | 24.47 | -0.97% | 851,800 | |
| 09 Nov 2026 | 24.41 | 25.09 | 24.22 | 24.71 | +2.07% | 628,800 | |
| 06 Nov 2026 | 24.06 | 24.80 | 23.71 | 24.21 | -3.78% | 775,400 | |
| 05 Nov 2026 | 25.74 | 26.39 | 24.32 | 25.16 | +6.29% | 1,573,000 | |
| 04 Nov 2026 | 24.11 | 24.48 | 23.42 | 23.67 | -0.25% | 804,000 | |
| 03 Nov 2026 | 23.67 | 23.92 | 23.49 | 23.73 | +0.21% | 524,900 | |
| 02 Nov 2026 | 23.96 | 24.08 | 23.25 | 23.68 | -0.50% | 600,700 | |
| 30 Oct 2026 | 24.28 | 24.50 | 23.66 | 23.80 | -0.96% | 401,900 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Wall Street Analysts Believe Collegium Pharmaceutical (COLL) Could Rally 81.63%: Here's is How to Trade (opens in a new tab) Zacks · 10 Nov 2026 13:55
- COLL Q3 2026 deep dive: ADHD portfolio drives growth as pain business stabilizes (opens in a new tab) StockStory · 10 Nov 2026 10:37
- Collegium Pharmaceutical (COLL) Stock Gets Fair Value Trim As Analysts Weigh Pain And ADHD (opens in a new tab) Simply Wall St. · 10 Nov 2026 07:10
- Collegium Pharmaceutical, Inc. (COLL) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 21:14
- Collegium Pharmaceutical, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 07 Nov 2026 21:04
- Collegium Pharmaceutical Inc (COLL) (Q3 2026) Earnings Call Highlights: ADHD Franchise Hits ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 21:09
- Piper Sandler Maintains Neutral on Collegium Pharmaceutical, Lowers Price Target to $28 (opens in a new tab) Benzinga · 06 Nov 2026 10:21
- Collegium Pharmaceutical, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 23:28
- Collegium (COLL) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:13
- Collegium Pharmaceutical Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 15:14
- Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 05 Nov 2026 13:35
- Collegium Pharmaceutical (NASDAQ:COLL) Posts Mixed Q3 as EPS Beats, Revenue Misses, and Guidance Holds (opens in a new tab) ChartMill · 05 Nov 2026 13:34
- Collegium Pharmaceutical (NASDAQ:COLL) posts in line Q3 2026 sales and full year revenue guidance above estimates, stock soars (opens in a new tab) StockStory · 05 Nov 2026 13:33
- Compared to Estimates, Collegium Pharmaceutical (COLL) Q3 Earnings: A Look at Key Metrics (opens in a new tab) Zacks · 05 Nov 2026 13:30
- Needham Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $44 (opens in a new tab) Benzinga · 05 Nov 2026 13:29
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 24.81 USD
- Market cap
- 762.3M
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow COLL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.